As of 2026-05-20, the Intrinsic Value of Allied Healthcare Products Inc (AHPI) is 882.28 USD. This AHPI valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 0.55 USD, the upside of Allied Healthcare Products Inc is 160,285.50%.
The range of the Intrinsic Value is 550.23 - 1,609.30 USD
Based on its market price of 0.55 USD and our intrinsic valuation, Allied Healthcare Products Inc (AHPI) is undervalued by 160,285.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (635.03) - (516.98) | (554.02) | -100813.2% |
| DCF (Growth 10y) | 550.23 - 1,609.30 | 882.28 | 160285.5% |
| DCF (EBITDA 5y) | (360.27) - (352.06) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | 368.25 - 469.18 | 395.50 | 71796.0% |
| Fair Value | -918.57 - -918.57 | -918.57 | -167,081.46% |
| P/E | (4,750.81) - (4,952.89) | (4,794.90) | -871741.0% |
| EV/EBITDA | (2,295.13) - (2,365.71) | (2,277.49) | -414114.1% |
| EPV | (1,393.92) - (1,458.50) | (1,426.21) | -259363.6% |
| DDM - Stable | (25.36) - (83.80) | (54.58) | -10021.8% |
| DDM - Multi | (1.19) - (3.89) | (1.93) | -451.4% |
| Market Cap (mil) | 0.02 |
| Beta | 1.46 |
| Outstanding shares (mil) | 0.03 |
| Enterprise Value (mil) | 7.27 |
| Market risk premium | 5.00% |
| Cost of Equity | 356.21% |
| Cost of Debt | 7.02% |
| WACC | 7.20% |